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Abstract
Glycoproteomic analyses of tryptic (glyco)peptides from wild-type (WT) 
porcine IgG were performed. In a first protocol, intact antibody was digested 
with trypsin, followed by glycopeptide enrichment and liquid chromatography-
tandem MS (HPLC–MS/MS). This procedure allowed to detect N-glycopeptides 
observed previously (Lopez, P. G. et al., Glycoconj. J. 2016, 33 (1), 79), plus other 
non-reported N-glycopeptides. The method provided useful information but did 
not allow to discern between Fab (antigen-binding region) and Fc (constant region, 
fragment crystallizable) peptides/glycopeptides. In a second scheme, glycopro-
teomic analysis was attempted for Fab and Fc fragments obtained by papain and 
Fabulous™ hydrolysis. Usually employed for milligram amounts of antibodies, 
the papain and Fabulous™ protocols were adapted to 200 μg of WT IgG. Fab and 
Fc fragments were separated by size-exclusion (SEC) HPLC. Fractions collected 
were reanalyzed by gel electrophoresis (SDS-PAGE). Bands were excised, and 
fragments digested in-gel, followed by matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) MS and HPLC/MS–MS. In the protocol no glyco-
peptide enrichment was involved, that is, whole tryptic digests were analyzed. Fc 
N-glycopeptides were identified, and greater numbers of non-glycosylated peptides 
were tabulated. Very few peptides overlapped between Fc and Fab, as most peptides 
were clearly from Fc or Fab. HPLC-MS/MS detected more sialylated glycoforms 
than MALDI-TOF-MS. Sections of Fab and Fc were assigned de novo, through a 
database search or manually.
Keywords: porcine IgG, papain, enzymatic fragmentation, Fabulous™, 
glycoproteomics
1. Introduction
There have been reports on the mass spectrometric (MS) analysis of pig immu-
noglobulins (IgG) in relationship with use in a xenotransplantation context [1–4]. 
These studies have explored the amino acid composition and glycosylation of pig 
IgG according to glycoproteomic [2, 3] and glycomic [1] workflows involving the 
enzymatic digestion of whole antibodies. Glycoproteomic workflows resulted in the 
Recent Advances in Analytical Chemistry
2
identification of many peptides that could be matched with the conserved gamma 
portion of the heavy chains of some of the 11 subtypes of pig IgG [5], including 
N-glycopeptides EEQFNSTYR and EAQFNSTYR [3]. No specific information was 
given on the variable portions of neither Fab nor Fc components, as most of such 
assignments would have had to be attributed de novo. The conserved Fc glycosyl-
ation site is often described as the only IgG site glycosylated at 100%, in spite of the 
fact that 10–15% of wild-type antibodies have glycosylation also in their variable 
region [6], and reports have shown that even higher glycosylation levels (up to 
30–40%) can exist in the variable regions of polyclonal IgGs [7, 8].
For more specificity, the analysis of antibodies by MS can take great advantage 
of enzymatic fragmentation with papain [9, 10] or new enzymes produced by 
recombinant methods and available on the market [11]. This type of procedure has 
not been reported for the fragmentation of porcine IgG, to the authors’ knowledge. 
For instance, procedures have been published for mouse [12, 13], chicken [14], 
rabbit [15], sheep [16], and human [17, 18] IgGs. The two groups of antibody 
fragments of primary interest are the antigen-binding fragments (Fab) and 
class-defining crystallizable fragments (Fc). The hinge region of immunoglobulins 
(IgGs) is readily accessible to proteolytic attack by enzymes [9, 10], and cleavage 
at that point produces F(ab’)2 or Fab fragments and the Fc fragment. Papain is a 
nonspecific thiol-endopeptidase and has a sulfhydryl group in its active site, which 
must be reduced for activity. When IgG molecules are incubated with papain in 
the presence of a reducing agent, one or more peptide bonds in the hinge region 
are split, producing three fragments of similar size: two Fab fragments and one Fc 
fragment [9, 10].
Fabulous™ enzyme is a recombinant cysteine protease that under reduced 
conditions digests in the hinge region of antibodies from many species and sub-
classes, including human, mouse, rat, and goat, yielding Fab and Fc fragments [11]. 
As a reducing agent is present during digestion, it is likely that interchain thiols 
will be reduced. Fabulous™ and papain have typically been used for the production 
of relatively large amounts of antibody fragments (10 mg of starting material), 
whereas methods adapted to MS require much less, about 50–200 μg. There is a 
need for downscaling these workflows, especially for porcine IgG, which has not 
been previously studied by fragmentation followed by MS.
Reports on post-fragmentation MS analyses of antibodies have demonstrated 
that detailed fragment characterization allows for the identification of more 
glycosylation sites than bottom-up approaches [19, 20]. It is also important to study 
amino acid sequences of the variable portions of IgG for therapeutic purposes [21], 
and the information obtained after fragmentation is much more specific than data 
generated through the tryptic digestion of whole intact antibodies.
The interest of the present study is to compare results from two main work-
flows aimed at characterizing wild-type porcine IgG’s glycosylation and amino 
acid sequence features. In the first workflow, porcine IgG is digested with trypsin, 
followed by glycopeptide enrichment. Reversed-phase high-performance liquid 
chromatography (RPLC) coupled with electrospray ionization (ESI) MS and 
tandem MS (MS/MS) is used to characterize the glycopeptide-rich fraction. The 
second workflow involves subjecting porcine IgG to fragmentation by one of two 
enzymes, papain or Fabulous™. The steps necessary between fragmentation and 
MS included size-exclusion chromatography (SEC), sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE), and tryptic digestion. This is the first 
attempt to characterize porcine IgGs in small amounts (sub-mg) using a combina-
tion of these methods. Two different MS techniques were used for the analysis of 
tryptic products of antibody fragments: matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) MS and ESI/MS–MS coupled with RPLC.
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As the tryptic digestion products of whole wild-type porcine IgG antibodies 
have been characterized by MALDI-MS [2, 3] and ESI-MS and MS/MS (new results 
presented in this report), data from these different workflows serve as comparative 
benchmarks between intact and fragmented IgG samples. Overlaps and differences 
allow to identify peptides and glycopeptides as originating from either the Fc or Fab 
portions, and database searches [22] can verify if these sequences are already available 
in the literature or need to be determined de novo. Porcine IgG is a complex mixture of 
subtypes, and the complementarity of MALDI- and LC/ESI-MS–MS brings a consider-
able amount of information to document the identification of these IgG components.
2. Experimental
2.1 Materials
Wild-type porcine IgGs were obtained from Université de Nantes (Dr. Jean-Paul 
Soulillou’s Laboratory). Trypsin Ultra™ was purchased from Promega (Wisconsin, 
USA). The Fabulous™ enzyme was kindly provided by Genovis (Cambridge, MA). 
Dihydroxybenzoic acid (DHB), sinapinic acid, ammonium bicarbonate, dithioth-
reitol (DTT), L-cysteine, iodoacetamide (IAA), and trifluoroacetic acid (TFA) were 
purchased from Sigma-Aldrich (St. Louis, MO). Mini-Protean TGX precast gels 
(4–15%), Precision Plus™ protein standard, 2-mercaptoethanol, and 4x Laemmli 
sample buffer were obtained from Bio-Rad (Hercules, CA). Imperial™ protein 
stain, tris base (2-amino-2-(hydroxymethyl)-1,3-propanediol) and immobilized 
papain-cross linked and 6% in beaded agarose supplied as 50% glycerol in sodium 
acetate pH 4.5 were purchased from Thermo Scientific (Rockford, IL). Strata-X C-18 
cartridges were obtained from Phenomenex (Torrance, CA). Acetonitrile (ACN) was 
purchased from EMD-Millipore (Darmstadt, Germany). Sodium phosphate dibasic 
anhydrous was purchased from McArthur Chemical Co. Ltd. (Montreal, Canada). 
Hydrochloric acid was purchased from Anachemia (Vancouver, Canada) and deion-
ized water was obtained from an adapted filtration system (Millipore).
2.2 Tryptic digestion of whole porcine IgG
Porcine IgG (200 μg) was dissolved in 100 mM ammonium bicarbonate (pH~8) 
and vortexed. A DTT solution (10 mM) was added to the sample, which was then 
vortexed and left to react at 56°C for 40 min, then cooled to room temperature. 
After 500 mM IA was added, and the sample was left to react in the dark for 
45 min. The excess of IA was quenched with the addition of 100 mM DTT, and 
the sample was left to react for 10 min in the dark. Trypsin was added and prote-
olysis took place at 37°C for ~18 h. To deactivate trypsin, the sample was frozen 
and dried under vacuum. Glycopeptide enrichment was then performed using a 
ProteoExtract™ glycopeptide enrichment kit (Millipore-Sigma, Etobicoke, ON) 
according to the manufacturer’s procedure [23].
2.3 Papain digestion of porcine IgG
Just before use, 20 mM sodium phosphate digestion buffer was prepared with 
a 10 mM cysteine content, and the pH was adjusted to 7 Bead-immobilized papain 
slurry (20 μL, 50%) was added to an Eppendorf™ tube. The beads were washed 
twice with 160 μL of digestion buffer and then re-suspended in the buffer. Porcine 
IgG (200 μg) was dissolved in the digestion buffer. This was added to the tube 
containing the washed immobilized papain and digestion buffer. The sample was 
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incubated for ~24 h at 37°C. Constant mixing of the bead slurry was maintained 
during the whole incubation. The bead-immobilized enzyme was separated from 
the digest by centrifugation and 20 μL of 10 mM Tris–HCl, pH 7.5 was added before 
centrifugation. The supernatant, which contained the IgG fragments, was removed.
2.4 Fabulous™ digestion for porcine IgG
The IgG sample (200 μg) was added to 200 units of Fabulous™ enzyme in 
200 μL of 10 mM Tris, 50 mM cysteine buffer. The sample was vortexed and 
incubated at 37°C for 1 h.
2.5 Fractionation of IgG fragments by HPLC using a SEC column
The digestion mixtures were injected into a preconditioned SEC-300 4.6 × 
300 mm silica-based column (Phenomenex, Torrance, CA). The mixtures were 
eluted with a mobile phase of 0.1% TFA, 0.1% formic acid in 20% ACN at a flow 
rate of 0.3 mL/min (manufacturer’s recommendation). The HPLC system used was 
a Waters 1525 binary pump equipped with a Waters 2707 autosampler and a Waters 
2998 photodiode array detector (Milford, MA). Fractions were collected, dried, and 
re-suspended for MALDI-MS analysis.
2.6 Separation of IgG fragments by SDS gel electrophoresis
Once fractionated by SEC, Fab and Fc components were separated on a 
Mini-Protean™ Tetra cell system (Bio-Rad). Bio-Rad TGX™ gels used had 10 
wells and a density gradient of 4–15%. Wells were washed individually four times 
with running buffer (10 × tris-glycine-SDS buffer diluted 1 × with water) prior 
to the loading samples. Each sample fraction containing Fab, Fc, or both Fab and 
Fc had its own lane on the gel. Each gel was loaded with 15 μL of each fraction 
(in water) in 11.3 μL of 4 × Laemmli sample buffer, without adding 2-mercapto-
ethanol. Well 1 was loaded with 10 μL of Precision Plus Protein Kaleidoscope™ 
standard. Intact-reduced IgG (15 μL, ~14 μg) was loaded into well 2. IgG frag-
ments (~14 μg) were loaded in other lanes. Running buffer was poured in the 
cell system and the voltage was set at 150 V. Samples were allowed to migrate for 
40 min, until the dye front reached the bottom of the gel. The gel was removed 
from the cell and was rinsed four times with Millipore water, and sufficient 
Imperial™ protein stain was added. IgG fragments absorbed the stain overnight, 
and the stain was decanted and replaced with Millipore water until gel bands 
became visible.
2.7 In-gel tryptic digest of IgG Fab and Fc fragments
Non-reduced Fab and Fc bands were excised from the gel. Tryptic digestion 
was performed on each single cut out band. Bands were cut into small pieces and 
placed into 1.5 mL Eppendorf tubes. The digestion buffer was 50 mM ammonium 
bicarbonate in water. Each tube contained one lane worth of gel. Gel pieces were 
washed with wash buffer (1:1 digestion buffer-ethanol) until all protein stain was 
removed. They were then incubated in absolute ethanol for 10 min. Gel pieces 
were then rewashed with digestion buffer for 20 min and then incubated again in 
absolute ethanol for 20 min, which was removed from the gel by vacuum centrifu-
gation. Trypsin solution was added and the tubes were placed on ice where the gel 
was allowed to swell. Thereafter, excess trypsin solution was discarded. Gel pieces 
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were covered with digestion buffer and incubated at 37°C for ~18 h. Glycopeptides 
and peptides were extracted on C18 cartridges with buffer A, 0.5% acetic acid; 
extraction buffer B, 5:3 30%; ACN, 0.5% acetic acid; and extraction buffer C, 100% 
ACN. Samples were dried down for further analysis.
2.8  Peptide-N-glycosidase F (PNGase F) removal of glycans from trypsin 
digested Fab and Fc fragments
A solution of PNGase F (4 μL, 10 units/μL) was added to a solution of tryptic 
glycopeptides. The sample was vortexed and set at 37°C for ~18 h. After the digest, 
glycans were separated from the de-glycosylated peptides on a C18 cartridge. The 
cartridge was conditioned with 5 x 1 mL (ACN + 0.1% TFA), then 5 × 1 mL of 
(H2O + 0.1% TFA). The sample was loaded onto the cartridge and allowed to equili-
brate for about 1–2 min. Glycans were eluted with 3 mL H2O + 0.1% TFA and col-
lected in two fractions. Peptides were eluted with 1.5 mL of 50:50 ACN:H2O + 0.1% 
TFA. Solvent was evaporated from the fractions.
2.9 Preparation of samples for MALDI-MS analysis
Glycopeptide fractions were mixed directly with 5 μL of DHB in 30:70 ACN: water. 
Samples (1 μL) were then spotted onto the stainless steel target and allowed to dry, for 
reflector positive mode MALDI-MS. For the Fab and Fc fragments from HPLC frac-
tions, 5 μL of 0.1% TFA and 5 μL of sinapinic acid in 0.1% TFA, 30:70 ACN: water was 
added, and 1 μL was spotted onto the target already pre-spotted with 0.5 μL of sinapinic 
acid in ethanol. Spots were then allowed to dry for linear positive mode MALDI-MS.
2.10 MALDI-TOF-MS analysis
These analyses were performed on an UltraFleXtreme™ mass spectrometer 
(Bruker, Billerica, MA) equipped with LID-LIFT™ technology for tandem MS 
experiments. For positive ionization mode, a nine-peptide calibration mixture with 
masses ranging from 500 to 5000 Da was used. In linear positive mode, the instru-
ment was calibrated using tryptic peptides of cytochrome C, mass ranging from 
10,000 Da to 160,000 Da.
2.11 Preparation of samples for HPLC-ESI-MS analysis
For the Fab and Fc tryptic digest fragments, 100 μL of water was added to the 
pooled C18 cartridge fractions of each Fab and Fc tryptic digests. Samples were 
sonicated and then ready for HPLC–MS analysis.
2.12 RPLC-MS/MS analysis of Fab and Fc tryptic digests
Both digestion mixtures (50 μL) were in turn injected into a preconditioned 
Acquity BEH C18 (1.7 μm, 2.1 × 50 m) silica-based, reverse phase column, on a 
Waters Acquity UPLC system (Waters, Mississauga, ON). The flow rate was 
0.25 mL/min, and a linear increase from zero to 28% ACN in water with 0.1% 
formic acid was used. Mass spectrometric detection was performed on a Waters G2 
Synapt ESI-MS instrument. Positive ionization mode was used. The analyzer mode 
was set to high resolution, with a capillary voltage of 3.00 kV and a cone voltage of 
25 V. The Progenesis™ software was used to handle and search databases for these 
HPLC-MS/MS analyses.
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2.13 Analysis of whole porcine IgG tryptic digest by RPLC-MS/MS
Separations were conducted on a LC Ultra system (Eksigent, Dublin, CA). A 
100 μm × 200 mm analytical column packed with 3 μm Luna C18 (Phenomenex, 
Torrance, CA) was used, at 500 nL/min flow rate. A 300 μm × 5 mm PepMap 100 
trap-column (Thermo Fisher, San Jose, CA) was used to protect the analytical 
column. The elution gradient was as described above. A Triple TOF 5600 mass spec-
trometer (ABSciex, Concord, ON) was used in standard MS/MS data-dependent 
acquisition mode. Mass spectra (250 ms) were collected (m/z 370–1250) and 
followed by up to 20 MS/MS measurements on the most abundant parent ions (400 
counts/s threshold, +2 to +5 charge state, m/z 100–1500 mass range for MS/MS, 
100 ms each). Database search was performed using the Global Proteome Machine 
(GPM) proteomics data analysis system [24].
3. Results and discussion
3.1 Mass spectrometric analysis of tryptic digests of whole porcine IgG samples
In previous studies, wild-type porcine IgG was digested with trypsin, and glyco-
peptides/peptides were fractionated on a C18 cartridge. Glycopeptide fractions were 
analyzed by MALDI-MS/MS [2, 3, 30]. In a new separate experiment, the results 
of which are presented here, all tryptic products were then enriched for glycopep-
tides using an EMD-Millipore ProteoGlycan™ kit [23]. The glycopeptide-enriched 
fraction was injected into a RPLC-MS/MS system, using data-dependent MS/MS 
acquisition. Figure 1a shows the MS/MS total ion chromatogram (TIC) obtained 
from the elution, whereas Figure 1b represents the elution of peptides with m/z 204 
Figure 1. 
(a) Total HPLC/MS ion chromatogram obtained from the MS/MS spectra of porcine IgG tryptic peptides 
and glycopeptides after enrichment on EMD-Millipore Proteoglycan™. (b) Selected MS/MS fragment ion 
chromatogram at m/z 204, indicating the elution times of glycopeptides [25].
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ions as product in their MS/MS spectra, identified as glycopeptides [25]. Although 
enrichment was performed, there were still non-glycosylated peptides present in 
the sample. The m/z 204 trace shows that glycosylated peptides eluted early in the 
analysis and that the most abundant compounds eluting in (a) were most probably 
non-glycosylated peptides.
A database search using GPM [24] helped to identify some non-glycosylated 
peptides, while for glycopeptides the extracted m/z 204 chromatogram was used 
to manually identify as many glycopeptides as possible. Table 1 gives a listing of 
all peptides detected and sequenced with GPM [24] or manually. For glycopeptide 
sequencing, MS/MS spectra were treated with CycloBranch [26] after removing 
abundant glycopeptide ions. As a few sequences are available in UniprotKB [22] for 
the Fc gamma portion of porcine IgG (K7ZLAZ, L8B180, L8B0S7, L8B0S2, L8B0Z4), 
and more are available [3] from previously published DNA sequences [5], some 
peptides show more than one identification source in Table 1. Only one entry was 
found for a porcine IgG Fab portion, P01846, which corresponds to the lambda (λ) 
constant region. Figure A1 compares the published porcine IgG Fc heavy chain 
sequences relating to Table 1 assignments.
Points of interest arising from this table are (i) the presence of a large number 
of non-glycosylated, even after enrichment, from the Fab and Fc portions of the 
antibody and (ii) the detection of seven distinct glycosylated peptides, some 
with complex glycoforms and one with high-mannose glycoforms, thus of the 
N-type. Indeed, all MS/MS spectra of these glycopeptides showed characteristic 
fragment ions corresponding to the (M + H)+ ions of the bare peptides, next to 
the characteristic (M + H + 83)+ and (M + H + 203)+ ions [27], with the latter 
being predominant.
Figure 2 shows four MS/MS spectra of glycopeptides, starting with two of 
the complex G0F forms of peptides of (a) constant region EAQFNSTYR [3] and 
(b) a variable region sequence partially determined as H2N-(300)-QNFSVFR by 
the CycloBranch software [26]. In these cases, the mass difference between the 
protonated precursors and (M + H)+ bare peptide fragments is 1444. The m/z 204 
and 366 fragment ions are predominant as glycopeptide signature. In Figure 2c, a 
sialylated complex glycoform is featured, the G1FS form of peptide EEQFNSTYR 
[3]. In previous studies of wild-type pig IgG, the presence of N-glycolyl neuraminic 
acid (NeuGc) is featured exclusively (i.e., no N-acetyl neuraminic acid (NeuAc)) 
has been reported [2, 3]. The fragmentation of NeuGc-containing species pro-
duces distinctive m/z 308 and 290 fragments, as observed in (c). Figure 2d shows 
the fragmentation of a high-mannose glycoform of a peptide of undetermined 
sequence. The bare peptide (M + H)+ ions appear at m/z 1069, with +83 ions (m/z 
1152) and + 203 ions (m/z 1272).
For known peptide sequences such as in Figure 2a and c, it is possible to find 
most bare peptide y and b ions, although they appear with very low abundance and 
are not accounted for by the search engine, due to the domination of all glycopep-
tide signature ions. There was an attempt by the authors to sequence all unknown 
glycopeptide sequences, with partial success, as indicated in red in Table 1.
Overall results suggest that N-glycosylation occurs in the Fc but also in the vari-
able regions of the Fab and/or Fc domains of porcine IgG. Each glycosylated peptide 
detected indicated patterns linked to N-glycosylation, while there was no obvious 
detection of O-glycans. This may be due to the conditions used to enrich the gly-
copeptides with the EMD-Millipore Kit, which were optimized for N-glycosylated 
peptides [23, 28]. Results obtained with this first workflow will be compared 
with those generated with a more elaborated procedure involving fragmentation 
enzymes as discussed below.
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Peptide sequence m/z (M + H)+ Error (ppm) m/z glycoform Glycoform Identification source*
Unknown 646.35 Unavailable
NFSTYR 787.37 0 2231.14 2392.28 2701.08 
2863.10
G0F G1F G1FS G2FS IgG1a-b,IgG2a-b,IgG4a-
b,IgG5a-b, IgG6a-
b,L8B0S7,L8B0S2,K7ZLA7,L8B180, 
L8B0Z4
LLVELIR 855.57 4.44 Unavailable
TVTPSECA 864.38 3.8 P01846
FSGAISGNK 880.45 2.72 P01846
DLPAPTIR 882.5 −4.88 IgG2ba-b,IgG4a-b,IgG6a-
b,L8B180,L8B0S7,L8B0Z4
LLLDLFR 889.55 −0.56 Unavailable
LLNGYRR 891.52 −4.6 Unavailable
AGGTTVTQVE 962.48 1.14 P01846
LIYQATNR 978.54 3.37 IPR 007110 (Ig C1-set)
VDPALPLEK 981.56 −1.58 Unavailable
NRPTGVPSR 983.54 −1.9 Unavailable
TISKATGPSR 1017.57 1.28 IgG3
LSSPATLNSR 1045.56 −3.44 Unavailable
Unknown 1069.55 2933.2 M9 Unavailable
FQQTPGQPPP 1096.54 −2.09 P01846
EAQFNSTYR 1115.49 −19.4 2414.05 2560.12 2722.15 
2884.24 3029.35 3191.50
G0 G0F G1F G2F 
G1FS G3F
IgG6a,L8B180,L8B0Z4
Unknown 1154.53 2599.1 G0F Unavailable
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Peptide sequence m/z (M + H)+ Error (ppm) m/z glycoform Glycoform Identification source*
EEQFNSTYR 1173.5 −14.6 2471.01 2618.09 2634.07 
2780.13 3087.23 2942.19 
3104.23 3249.28 2833.04
G0 G0F G1 G1F 
G1FS G2F G3F G2FS 
M9-N
IgG1a-b,IgG2a-b,IgG4a-b,IgG5ab,IgG6b, 
L8B0S7,L8B0S2,K7ZLA7
TNNRPTGVPSR 1198.63 Unavailable
H2N-300-QNFSVFR 1212.13 2656.09 2819.14 2981.20 G0F G1F G2F Unavailable
SYLALSASDWK 1240.62 −0.64 P01846
DTNRPSGIPER 1241.62 −2.6 Unavailable
STNSRPTGVPSR 1258.65 0.16 P01846
FSGSGSGTDFTLK 1303.62 2.74 Unavailable
SSSGFTCQVTHE 1339.56 1.27 P01846
TAPSVYPLAPCGR 1388.71 7.85 IgG1a-b,IgG4b,IgG5b,IgG6b,L8B180,K7
ZLA7,L8B0Z4
LLGASVLGVGDIHR 1406.81 1 Unavailable
Unknown 1415.62 Unavailable
Unknown 1467.28 2911.26 3073.31 G0F G1F Unavailable
Unknown 1495.73 Unavailable
LVESGGGLVQPGGSLR 1525.85 11 L8B0S2,L8B180,L8B0S7
QSNNKYAASSYLAL 1529.76 0.39 P01846
AGGTTVTQVETTKPSK 1604.85 0.6 P01846
YAASSYLALSASDWK 1632.79 0.24 P01846
VVSVLPIQHQDWLK 1661.92 −10.4 IgG1a-
b,IgG3,IgG6b,L8B180,K7ZLA7,L8B0Z4
QEYREDFVLTVTGK 1667.83 12.7 Unavailable
APASYFVQSVLTVSAK 1667.9 0 K7ZJP7
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Peptide sequence m/z (M + H)+ Error (ppm) m/z glycoform Glycoform Identification source*
Unknown 1718.91 Unavailable
TVIYSTNSRPTGVPSR 1734.91 1.73 P01846
QLIYSTNNRPTGVPSR 1802.95 3.88 Unavailable
QLIYQTNSRPTGVPSR 1816.97 1.98 IPR 007110 (Ig-like)
SSSGFTCQVTHEGTIVEK 1966.92 1.32 P01846
AAPTVNLFPPSSEELGTNK 1972 1.06 P01846
ASGVPDRFSGSGSGTDFTLK 1985.96 1.86 Unavailable
FTDETLVSDLQPSLDRAR 2063.04 0.15 Unavailable
ATLVCLISDFYPGAVTVWK 2083.1 3.26 P01846
AGPLGWFERRPEPPPGPPSK 2172.14 2.39 Unavailable
QSNNKYAASSYLALSASDWK 2204.06 0.82 P01846
Unknown 2717.07 Unavailable
Unknown 2832.04 Unavailable
*L8B180,L8B0Z4,L8B0S2,L8B0S7,K7ZLA7 porcine IgG heavy chain entries (Fc) [22]; P01846, porcine IgG lambda constant domain (Fab); K7ZJP7, IgM heavy chain; P01786, mouse IgG heavy chain; 
P01857, human IgG heavy chain; IgGs. from [3]; IPR, GPM entries.
Table 1. 
Masses and sequences of peptides found in a glycopeptide-enriched fraction from porcine IgG (wild-type) tryptic digestion products. Red: Labeled manually; black: Sequenced and/or matched by 
GPM [24]. Glycopeptides, m/z values in bold not observed, only glycoforms.
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3.2  Fragmentation of porcine wild-type IgG with papain and fabulous™ 
followed by SEC
Antibody samples were first fragmented on immobilized papain, and thus it is 
expected that only IgG-related products will be present in the mixture. As shown 
by Figure 3a, all antibody was fragmented (intact antibody would have appeared at 
ca. 4.5 min). In general, when IgG is incubated with papain with a reducing agent, 
one or more peptide bonds in the hinge region are split, producing three fragments 
of similar size: two Fab fragments and one Fc fragment. The Fc may remain intact 
Figure 2. 
Tandem mass spectra of doubly or triply charged ions of glycopeptides enriched from the tryptic products of 
porcine wild-type IgG. (a) G0F glycoform of EAQFNSTYR, (b) G0F of undetermined peptide, (c) G1FS of 
EEQFNSTYR, (d) Man-9 of undetermined peptide.
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based on conditions and enzyme used [9, 10]. The cleavages occur at cysteines 
around position 271 (in Figure A1), about 10 amino acids from the IdeS cleavage 
site [29]. In human IgG subtypes (IgG1-4), there are on average of three cysteines 
in the range of hinge region positions 265–275 to make the numbers correspond 
with those of Figure A1, where papain cleavages can be initiated [29]. Porcine IgG 
has similar cysteine motifs in these positions; however, Figure A1 shows different 
lengths of amino acid chains in the hinge region, which did not seem to prevent 
fragmentation. Interestingly in this papain-fragmentation experiment, the Fc did 
not remain intact, but the Fab did. Figure 3a shows significant separation although 
not at the baseline, but which still allowed the collection of Fab and Fc fractions.
In order to further isolate Fab and Fc segments, collected fractions were analyzed in  
turn by SDS-PAGE. This allowed identification by mass, with confirmation by linear 
mode MALDI-TOF-MS (not shown) and in-gel tryptic digestion of the bands (analyzed 
by reflector mode MALDI-TOF-MS and HPLC-MS, next section). The first major peak 
in Figure 3a was identified as originating from the Fab, and the second peak was identi-
fied as the Fc. The intact Fab fragment is larger and thus elutes prior to the split Fc, while 
the opposite is usually true in the case of human IgG [15].
Fabulous™ is a recombinant cysteine protease which under reducing conditions 
digests in the hinge region of antibodies from many species and subclasses, including 
human, mouse, rat, and rhesus monkey, yielding Fab and Fc fragments [11]. Some 
specific fragmentation site information is available for human IgG1, mouse IgG1, 
and rabbit IgG, but no information at all pertains to the fragmentation of porcine 
Figure 3. 
Size exclusion chromatograms obtained for 200 μg of wild-type porcine IgG fragmented by (a) immobilized 
papain and (b) Fabulous™.
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IgG. Looking at all porcine IgG subtype sequences (see alignment in Figure A1), they 
have a motif similar to that of rabbit IgG (KP270I/CPP) [11], that is, with a potential 
fragmentation site between isoleucine I and cysteine C: CP270I/CPG or CP270I/CPA.
In general, when IgG molecules are incubated with Fabulous™ in the presence 
of a reducing agent, one or more peptide bonds in the hinge region are split next to a 
cysteine, producing two Fab fragments and one Fc. As the reducing agent is present 
during the digestion reaction, it is likely that all interchain thiols will be reduced.
In this experiment with Fabulous™ using 100 μg of pig IgG, a small portion of the 
antibody was not fragmented; otherwise the Fc was split into two halves and the Fab 
fragments remained intact. The HPLC-SEC chromatogram is shown in Figure 3b. The 
first major peak was indicative of the Fab fragment, and the second peak eluting after 
identified as the Fc, as verified later by SDS-PAGE and further tryptic digestion. As 
noticed in the chromatograms of Figure 3, elution times are different, that is, longer 
in portion b. This is due to gradual deterioration of the column, as both experiments 
depicted in a and b were performed several months apart.
The fact that Fabulous™ (28,724 Da [11]) was free in solution and not immobi-
lized as in the case of papain involves that it would elute in the SEC chromatogram 
(Figure 3b), most probably in the second peak with the Fc. If this proprietary 
enzyme has a sequence similar to that of papain, subsequent proteolysis by trypsin 
is likely to occur extensively, as many lysine and arginine residues are present in 
papain’s sequence [31].
3.3 SDS-PAGE separation of porcine IgG fragments
For papain-produced fragments, a nonreducing gel experiment was performed 
on the previously collected SEC fractions (Figure 4a). This experiment allowed 
confirming the identity of the fragments. A reducing SDS-PAGE experiment was 
also performed on intact pig IgG to serve as a control (Figure 4b). Bands were then 
excised from the gel, followed by in-gel tryptic digestion. This helped to single out 
heavy and light chains for differentiating between Fab and Fc according to their 
respective known glycopeptides and peptides [2, 3]. In Figure 4a, lanes 6–9 corre-
spond to a fraction containing both Fab and Fc collected at the junction of SEC peaks 
in Figure 3a. A single 50 kDa Fab band and two 25 kDa bands were obtained. The Fab 
band is positioned just below the 50 kDa marker band and clearly below the Fc band 
in Figure 4b, and the Fab should have a lower molecular weight than intact Fc [32]. 
Figure 4. 
(a) Fab and Fc SEC fractions from papain-fragmented porcine IgG on nonreducing SDS-PAGE and (b) from 
Fabulous™-fragmented porcine IgG, (c) whole porcine IgG runs under reducing conditions.
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Both bands appearing in the Fc region were digested independently with trypsin as 
denoted by “upper Fc band” and “lower Fc band.” It appears from further results that 
they belong to different IgG subtypes. For Fabulous™ fragments, the same experi-
ment was conducted and results are shown in Figure 4b. According to gel separa-
tions, papain and Fabulous™ had very similar fragmentation effects on porcine IgG.
3.4 MALDI-MS of in-gel tryptic-digested Fc bands
Figure 5a shows the tryptic products for the upper Fc band (papain generated) 
in Figure 4a. The main glycopeptide observed has three main glycoforms at m/z 
2472, 2618, and 2780 as [M + H]+ ions. In Figure 5b (lower Fc band), two series of 
glycopeptides are observed, that is, the same as above and another one at m/z 2414, 
2560, and 2722. The amino acid sequences of these glycopeptides were verified by 
MALDI-MS/MS as EEQFNSTYR and EAQFNSTYR, respectively [2, 3], with glyco-
forms as indicated in the figure. PNGase de-glycosylation of these two samples led 
to the spectrum of Figure 5c, where peptides at m/z 1117 (EAQFDSTYR) and 1175 
(EEQFDSTYR) were detected, while the analysis of released glycans was not suc-
cessful. Similar MALDI-MS and MS/MS results were obtained for the Fabulous™-
generated porcine IgG that combined upper and lower Fc fragments digested with 
trypsin. Besides glycopeptides from the Fc region, other Fc ɤ-domain peptides were 
observed, as identified from the database [22] in Table 2.
Figure 5. 
Reflector positive mode MALDI-TOF-MS spectra of (a) tryptic digestion products from pig IgG Fc fragment 
(higher 25 kDa band) and (b) lower Fc fragment. Both bands were excised from the gel run under non-
reducing conditions shown in Figure 4a. (c) De-glycosylated peptides after removal of glycans to give peptides 
at m/z 1117 and 1175.
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Peptide sequence m/z (M + H)+ Error ppm m/z glyco-form Glyco-form Source*
Unknown 807.28 Unavailable
Unknown 842.38 Unavailable
Unknown 870.41 Unavailable
DLPAPITR 882.5 −5.78 IgG2ba-b,IgG4a-b,IgG6a-b, L8B180,L8B0S7,L8B0Z4
Unknown 905.33 Unavailable
Unknown 951.33 Unavailable
Unknown 993.36 Unavailable
Unknown 1033.4 Unavailable
Unknown 1107.4 Unavailable
EAQFNSTYR 1115.5 −22.51 2560.39 G0F IgG6a,L8B180,L8B0Z4
Unknown 1165.4 Unavailable
EEQFNSTYR 1173.50 −14.6 2471.60 2779.62 2779.63 G0 G0F G1F IgG1a-b,IgG2a-b,IgG4a-b,IgG5a-b, 
IgG6b,L8B0S7,L8B0S2,K7ZLA7
Unknown 1209.5 Unavailable
Unknown 1261.4 Unavailable
VNNVDLPAPITR 1308.6 −66.51 IgG1a-b,K7ZLA7
Unknown 1330.4 Unavailable
SNGQPEPEGNYR 1347.6 −1.48 IgG1a,IgG6a-b,L8B180,L8B0S2, K7ZLA7,L8B0Z4
Unknown 1374.4 Unavailable
Unknown 1392.2 Unavailable
Unknown 1427.6 Unavailable
Unknown 1475.6 Unavailable
Unknown 1503.4 Unavailable
LVESGGGLVQPGGSLR 1525.7 −74.23 L8B180,L8B0S7
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Peptide sequence m/z (M + H)+ Error ppm m/z glyco-form Glyco-form Source*
VSSQNIQDFPSVLR 1589.8 42.9 K7ZJP7 (IgM HC const. region)
YAASSYLALSASDWK 1632.8 −24.5 P01846 UniprotKB (Ig λ const. region)
VVSVLPIQHQDWLK 1662 13.7 IgG1a-b,IgG3,IgG6b,L8B180,K7ZLA7, L8B0Z4
Unknown 1677.5 Unavailable
Unknown 1693.7 Unavailable
Unknown 1725.4 Unavailable
Unknown 1740.6 Unavailable
Unknown 1754.4 Unavailable
STGKPTLYNVSLVLSDT 1794.8 −60.4 K7ZJP7 (IgM HC const. region)
EPQVYTLSPSAEELSR 1805.8 −34.1 IgG6a-b,L8B180,L8B0Z4
EPQVYTLPPPAEELSR 1825.9 2.9 IgG1a-b,K7ZLA7
EPQVYTLPPPTEELSR 1855.9 −2.32 IgG4b
TTPPQQDVDGTFFLYSK 1943.8 −50.7 IgG1a-b,K7ZLA7
TTPPQQDVDGTYFLYSK 1959.9 −1.07 IgG2a-b,IgG3,IgG4a-b,IgG6a,L8B180, L8B0S7,L8B0Z4
AAPTVNLFPPSSEELGTNK 1971.9 −36.6 P01846 UniprotKB (Ig λ const. region)
Unknown 2135.8 Unavailable
Unknown 2162.9 Unavailable
Unknown 2211 Unavailable
GLEGLAYIGYTGVITDYADSVK 2305.4 86.8 L8B180
*L8B180,L8B0Z4,L8B0S2,L8B0S7,K7ZLA7, porcine IgG heavy chain entries (Fc) [22]; P01846, porcine IgG lambda constant domain (Fab); K7ZJP7, IgM heavy chain; P01786, mouse IgG heavy chain; 
P01857, human IgG heavy chain; IgGs, from [3]; IPR, GPM entries.
Table 2. 
Masses and sequences of peptides found by MALDI-MS in porcine IgG (wild-type) tryptic digestion products of combined Fc bands obtained by papain and Fabulous™ fragmentation. Peptides 
and glycopeptides in red were sequenced manually after MS/MS and/or tentatively identified by mass fingerprinting.
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3.5 In-gel tryptic-digested fab bands analyzed by MALDI-MS
The bands just below 50 kDa from both papain and Fabulous™ digestion 
processes were excised from the gel and digested with trypsin. MALDI-MS spectra 
of the products were obtained, and display no obvious glycopeptides as found in 
the Fc. Some peaks could be identified as light and heavy chain Fab peptides. Fab 
peptide masses and sequences available are listed in Table 3.
Sequence m/z ESI m/z MALDI Error 
ppm
Identification 
source
FSGAISGNK 880.45 880.39 −70.8 P01846 (Ig λ 
const. region)
Unknown 951.33 951.21 Unavailable
Unknown 993.36 993.56 Unavailable
Unknown 1052.22 Unavailable
Unknown 1119.29 Unavailable
Unknown 1141.26 Unavailable
Unknown 1209.48 1209.28 Unavailable
Unknown 1242.51 Unavailable
FSGSGSGTDFTLK 1303.62 1303.61 −4.91 Unavailable
Unknown 1339.55 Unavailable
Unknown 1374.27 Unavailable
Unknown 1383.95 Unavailable
Unknown 1419.30 Unavailable
Unknown 1476.02 Unavailable
Unknown 1503.39 1504.12 Unavailable
Unknown 1526.39 Unavailable
Unknown 1584.35 Unavailable
Unknown 1622.45 Unavailable
YAASSYLALSASDWK 1632.79 1632.85 36.7 P01846 (Ig λ 
const. region)
Unknown 1660.16 Unavailable
Unknown 1735.19 Unavailable
Unknown 1762.23 Unavailable
QLIYSTNNRPTGVPSR 1802.95 1803.00 27.73 Unavailable
Unknown 1826.41 Unavailable
Unknown 1866.38 Unavailable
Unknown 1910.24 Unavailable
Unknown 1942.26 Unavailable
AAPTVNLFPPSSEELGTNK 1972.00 1972.18 90.2 P01846 (Ig λ 
const. region)
Unknown 2034.37 Unavailable
FTDETLVSDLQPSLDRAR 2063.04 2063.17 62.9 Unavailable
Unknown 2135.81 2136.40 Unavailable
Unknown 2210.95 2211.46 Unavailable
Unknown 2338.64 Unavailable
Unknown 2377.63 Unavailable
Unknown 2408.38 Unavailable
VTLTCLVTGFYPPDIDVEWQR 2509.24 2509.39 58.5 IgG4a
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Overall, MALDI-TOF-MS experiments allowed suggesting that efficient separation 
of Fab and Fc fragments from each other occurred, using the SEC/SDS-PAGE proce-
dure. There was a minimal number of overlapping peptides between Fab and Fc MALDI 
spectra (Tables 2 and 3). In Table 3, peptides in red had already been sequenced and 
appeared in Table 1; peptides whose m/z values appear in the second column were also 
observed in Table 1, although not sequenced. Overlapping peptides between Tables 2 
and 3 are at m/z 2509 (unknown), 2884 (glycoform of m/z 1115), and m/z 1677 (IgM). 
The presence of IgM in the sample had been noticed in an earlier report [3].
3.6  Tryptic products of Fabulous™-fragmented porcine IgG analyzed by  
HPLC/MS
Each sample of digestion products from Fc and Fab bands were analyzed twice 
by HPLC/MS, and results are summarized in Table 4. In Figure A2, total ion 
chromatograms (TIC) of the pig Fab and Fc tryptic products showed differences 
in the retention times of some peaks as expected. Peaks observed at the same 
 retention times (e.g., 4.41–4.46, 10.35, and 23.10 min) and common to all injections 
 corresponded to singly charged ions of small compounds of m/z ˂ 700 and were 
not considered in the analysis, as they probably were non-peptide contaminants. 
Peaks at 5.96 min also present in both chromatograms corresponded to a mass 1660 
peptide from the Fab, AGGTTVTQVETTKPSK. Non-glycosylated peptides in 
Table 4 were identified through MS/MS and database search, while glycopeptides 
were assigned by mass only in reference to entries in Table 1.
As Fabulous™ was possibly still present in the mixture at the time of tryptic diges-
tion of the Fc gel band, analogous papain tryptic digestion products were sought for by 
m/z, but not found. Only one papain peptide with sequence YIDETNK (m/z 882.4203) 
could be present according to its nominal mass; however, the observed m/z 882.4998 
peptide ions are closer to the calculated mass of IgG DLPAPITR, 882.4939. As seen in 
Table 4, many peptides remain un-sequenced/unidentified, and others are identified 
as either Fab or Fc peptides of porcine IgG. Interestingly, there were some very good 
matches with human and mouse IgG, which is not surprising given relatively high lev-
els of homology between mammal species in general. However even with all the heavy 
chain sequences available in the literature for porcine IgG (see footnote of Table 4 and 
Figure A1), none of them contained the human- and murine-assigned peptides. It is 
also interesting to observe that most peptides are predominant in either the Fab or Fc 
injections and that overlapping peptides are clearly more present in one sample than 
in the other. Accordingly, all Fab P01846 peptides (m/z 880, 1175, 1274, 1375, 1533, 
1590, and 1661) were more abundant in the Fab than the Fc sample, although all these 
peptides showed some level of overlap. The same reasoning is applicable to Fc pep-
tides, including the N-glycoforms of EAQFNSTYR and EEQFNSTYR. It is also pos-
sible to know the origin of most unidentified peptides in Table 4 by comparing their 
normalized abundances. Other N-glycopeptides reported in Table 1 were not detected 
in these Fab and Fc RPLC/MS experiments, possibly due to the lack of glycopeptide 
enrichment and to sample loss during the SEC and SDS-PAGE procedures.
Sequence m/z ESI m/z MALDI Error 
ppm
Identification 
source
Unknown 2691.50 Unavailable
Unknown 2807.49 Unavailable
Table 3. 
Fab tryptic peptides from porcine IgG fragmented with papain and fabulous™. Second column (m/z ESI): 
Already identified in Table 1. Error: Measured using the MALDI m/z values against calculated values. 
Sequences in red are assigned from mass only based on Table 1.
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Mass (calc.) m/z (M + H) + (exp.) m/z error 
(ppm)
Normalized abundance Sequence Sources of identification*
Pig Fab wt (avg) Pig Fc wt (avg)
516.301 517.309 0.00 0.0 23.9 VDKR IgG1a-b,IgG2a-b,IgG3,IgG4a-b
585.322 586.330 −1.97 76.1 1972.6 PGGSLR P01786
712.372 713.380 −4.25 8.0 891.4 LVESGGGL P01786
768.412 769.420 0.0 9.4
806.345 807.353 652.0 22.4
811.439 812.447 −5.63 6.1 424.4 LVESGGGLV P01786
816.416 817.424 0.0 78.4
824.372 825.380 0.0 9.1
826.434 827.442 749.4 1176.6
827.511 828.519 478.3 166.0
834.421 835.429 0.0 65.1
837.492 838.500 −5.12 14.2 0.0 ALPAPIEK P01857
841.502 842.510 977.9 1260.9
844.291 845.299 264.0 0.0
850.418 851.426 0.0 42.4
861.432 862.440 220.3 52.3
872.373 873.381 0.0 74.7
872.397 873.405 0.0 15.5
879.445 880.453 −0.45 1559.7 479.8 FSGAISGNK P01846
881.492 882.500 −5.78 0.0 410.6 DLPAPITR IgG2ba-b,IgG4a-b, 
IgG6a-b,L8B180,L8B0S7,L8B0Z4
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Mass (calc.) m/z (M + H) + (exp.) m/z error 
(ppm)
Normalized abundance Sequence Sources of identification*
Pig Fab wt (avg) Pig Fc wt (avg)
888.366 889.374 0.0 44.9
917.391 918.399 254.9 54.6
919.450 920.458 17.9 135.1
935.856 936.864 2502.6 2690.0
939.510 940.518 7.61 86.4 407.8 LVESGGGLVQ P01786
990.341 991.349 264.4 5.6
994.506 995.513 13.2 518.7
994.512 995.520 7.6 311.7
1043.899 1044.907 1589.5 1690.0
1044.554 1045.562 −2.30 5106.9 6511.7 LSSPATLNSR Unavailable
1057.831 1058.839 1179.7 1190.5
1066.539 1067.547 −1.47 0.0 8.5 VDGVEVHNAK P01857
1103.601 1104.609 0.0 17.0
1164.577 1165.585 66.4 199.4
1174.613 1175.621 −5.01 468.4 169.5 TQGVETTKPSK P01846
1208.640 1209.648 0.0 790.8
1238.648 1239.656 1.6 343.5
1259.553 1260.561 3.7 480.5
1260.536 1261.544 15.5 1386.4
1273.685 1274.693 −1.89 324.0 104.5 VTQGVETTKPSK P01846
1296.678 1297.686 9.3 727.0
1298.485 1299.493 30.8 263.2
1302.609 1303.617 0.00 2446.2 908.9 FSGSGSGTDFTLK Unavailable
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Mass (calc.) m/z (M + H) + (exp.) m/z error 
(ppm)
Normalized abundance Sequence Sources of identification*
Pig Fab wt (avg) Pig Fc wt (avg)
1307.718 1308.726 −1.30 139.6 13772.8 VNNVDLPAPITR IgG1a-b,K7ZLA7
1308.702 1309.710 13.2 3997.2
1312.672 1313.680 −1.22 2.4 306.7 ESGGGLVQPGGSLR P01786
1316.625 1317.633 896.9 223.7
1329.687 1330.695 20.3 434.9
1330.670 1331.678 87.9 1324.0
1334.648 1335.656 23.1 374.1
1340.548 1341.556 131.8 45.0
1345.666 1346.674 5.8 2149.3
1346.587 1347.595 1.41 47.2 658.2 SNGQPEPEGNYR IgG1a,IgG5b,IgG6b,L8B180K7ZLA7,L8
B0Z4
1347.568 1348.576 50.8 1702.0
1350.620 1351.628 7.9 512.8
1368.616 1369.624 16.4 484.9
1374.732 1375.740 −2.30 742.1 219.7 TVTQGVETTKPSK P01846
1376.558 1377.566 457.8 61.0
1390.608 1391.616 3.4 308.0
1391.593 1392.601 6.6 898.0
1399.808 1400.816 1434.9 1503.7
1433.682 1434.690 8.5 226.8
1449.688 1450.696 17.8 958.3
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Mass (calc.) m/z (M + H) + (exp.) m/z error 
(ppm)
Normalized abundance Sequence Sources of identification*
Pig Fab wt (avg) Pig Fc wt (avg)
1514.667 1515.675 100.8 1436.0
1524.822 1525.830 −2.62 1005.8 20216.6 LVESGGGLVQPGGSLR L8B180, L8B0S7
1530.664 1531.672 0.3 599.0
1532.803 1533.811 −0.91 646.1 171.1 GTTVTQGVETTKPSK P01846
1546.798 1547.806 64.1 2405.4
1562.772 1563.780 192.8 4750.7
1578.744 1579.752 47.70 4.7 439.3 EEQFNSTYR +2GlcNAc IgG1a-b,IgG2a-b,IgG4a-b,IgG5a-
b,IgG6b,L8B0S7,L8B0S2,K7ZLA7
1589.823 1590.831 −1.93 647.8 181.7 GGTTVTQGVETTKPSK P01846
1624.841 1625.849 321.8 72.8
1642.851 1643.859 −0.92 1827.2 614.7 AGGTTVTQGVETTKPSK [C-term] neutral loss
1660.864 1661.872 0.26 11688.6 4028.5 AGGTTVTQGVETTKPSK P01846
1682.829 1683.837 346.8 77.9
1698.811 1699.819 1146.9 308.5
1719.703 1720.711 10.5 471.9
1735.702 1736.710 0.0 480.4
1753.805 1754.813 2.7 493.2
1769.797 1770.805 4.8 723.1
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Mass (calc.) m/z (M + H) + (exp.) m/z error 
(ppm)
Normalized abundance Sequence Sources of identification*
Pig Fab wt (avg) Pig Fc wt (avg)
1801.950 1802.958 3.60 191.0 99.2 QLIYSTNNRPTGVPSR Unavailable
1807.752 1808.760 4.8 287.3
1824.931 1825.939 2.90 4.0 670.0 EPQVYTLPPPAEELSR IgG1a-b,K7ZLA7
1854.932 1855.940 −2.32 0.0 1499.6 EPQVYTLPPPTEELSR IgG4b
1862.867 1863.875 0.0 695.8
1919.930 1920.938 1.8 0.0
1958.924 1959.932 −1.07 3.4 2082.2 TTPPQQDVDGTYFLYSK IgG4a-b, IgG6a, L8B180, L8B0S7, IgG2a, 
IgG2b, IgG3
2092.889 2093.897 649.7 14.8
2251.915 2252.923 0.0 750.1
2267.910 2268.918 0.0 356.8
2289.908 2290.916 0.0 72.8
2355.931 2356.939 0.0 62.0
2413.960 2414.968 −11.42 0.0 2793.9 G0 of EAQFNSTYR IgG6a,L8B180,L8B0Z4
2435.939 2436.947 0.0 86.5
2451.911 2452.919 0.0 90.0
2558.988 2559.995 −19.69 0.0 25.6 G0F EAQFNSTYR IgG6a,L8B180,L8B0Z4
2576.008 2577.016 0.0 439.0
2617.036 2618.044 −2.66 3.5 1257.9 G0F EEQFNSTYR IgG1a-b,IgG2a-b,IgG4a-b,IgG5a-
b,IgG6b,L8B0S7,L8B0S2,K7ZLA7
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Mass (calc.) m/z (M + H) + (exp.) m/z error 
(ppm)
Normalized abundance Sequence Sources of identification*
Pig Fab wt (avg) Pig Fc wt (avg)
2639.006 2640.014 0.0 706.3
2654.984 2655.992 2.5 1048.1
2670.955 2671.963 0.0 200.5
2692.958 2693.966 0.0 49.2
2779.092 2780.100 −1.36 0.0 1327.0 G1F EEQFNSTYR IgG1a-b,IgG2a-b,IgG4a-b,IgG5a-
b,IgG6b,L8B0S7,L8B0S2,K7ZLA7
2801.070 2802.078 2.8 244.1
2817.033 2818.041 0.0 380.8
2941.166 2942.174 5.90 0.0 266.4 G2F EEQFNSTYR IgG1a-b,IgG2a-b,IgG4a-b,IgG5a-
b,IgG6b,L8B0S7,L8B0S2,K7ZLA7
3004.216 3005.224 0.0 68.7
3086.182 3087.190 −1.33 0.0 159.4 G1FS EEQFNSTYR IgG1a-b,IgG2a-b,IgG4a-b,IgG5a-
b,IgG6b,L8B0S7,L8B0S2,K7ZLA7
*L8B180,L8B0Z4,L8B0S2,L8B0S7,K7ZLA7, porcine IgG heavy chain entries (Fc) [22]; P01846, porcine IgG lambda constant domain (Fab); K7ZJP7, IgM heavy chain; P01786, mouse IgG heavy chain; 
P01857, human IgG heavy chain; IgGs, from [3]; IPR, GPM entries.
Table 4. 
Tryptic peptides from pig IgG Fab and Fc fragment analyzed by HPLC-MS/MS.
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3.7 Comparative aspects of both workflows
The initial RPLC-MS/MS experiment on the enriched whole IgG digest 
produced the most useful information in terms of glycopeptides. Besides the 
latter, many peptides were identified as originating from the Fc or Fab portion, 
while for other peptides origin remained unknown. This first workflow allowed 
detecting N-glycopeptides from the Fab portion of the antibody, although their 
sequences could not be completely assigned. The second workflow necessitated 
more intensive work than the first one. Size-exclusion chromatography or 
SDS-PAGE was not sufficient on its own to properly separate Fab and Fc, and a 
combination of both was preferable. Even then, RPLC/MS results show partial 
overlaps for many peptides, although most peptides were much more abundant 
in one sample (Fc or Fab) than in the other. In terms of ionization modes used in 
the second workflow, ESI yielded more details on sialylated glycopeptides, but 
did not allow the observation of Fab N-glycopeptides. As analyses by MALDI 
were the result of depositing all tryptic products of a gel band onto one target 
spot, it is probable that the signals of sialylated glycopeptides or low concentra-
tion Fab glycopeptides were overtaken competitively by peptides that are more 
abundant.
4. Conclusions
Porcine immunoglobulins constitute a complex ensemble of biomolecules, with 
several subtypes whose amino acid sequences are not clearly assigned and described 
in the literature (see Figure A1). In this study, three state-of-the-art mass spectrom-
eters were used to characterize tryptic peptides, offering a considerable amount of 
complementary information owing to the great sensitivities of these instruments, 
given the small amounts of IgGs used. Indeed, fragmentation of porcine IgG into its 
Fc and Fab portions was achieved for the first time using papain and Fabulous™ on 
200 μg or less of antibody. Fragments needed separation by both SEC and SDS-
PAGE before analysis by MALDI-TOF-MS and HPLC/MS. These separation pro-
cedures did not eliminate the overlapping of Fab and Fc tryptic peptides entirely; 
however, there was a significant level of discrimination. This workflow resulted in 
better knowledge about the origin of tryptic peptides from IgG.
During the course of this work, the several sources of sequence information 
on porcine IgG found in Figure A1 were used to verify HPLC-MS/MS, MALDI-
TOF-MS, and HPLC-MS data. Most Fc peptides were from the gamma constant 
region, where some Fab peptides were identified as belonging to the constant 
portion of the lambda chain. The HPLC-MS/MS method of tryptic peptide with-
out previous Fab-Fc fragmentation was the most efficient in terms of useful data 
generated per amount of sample used, although many peptides could not be related 
to either Fc or Fab. This study highlights the need for detailed pertinent sequence 
information for porcine IgG, which is not a commonly studied set of biomolecules. 
Future work will involve the quantification of IgG subtypes according to unique 
peptide sequences that are already known in each subtype.
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Figure A1. 
Alignment of sequences available in the literature for the porcine IgG heavy chains. IgGn: from Ref. [3]. Others: 
UniprotKB [22].
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Figure A2. 
HPLC/MS total ion chromatograms obtained for the tryptic products of wild-type porcine IgG Fabulous™ 
fragments, (a) Fc and (b) Fab.
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